Refine search

To refine your search select one of the options below.

Body System	Antineoplastic And Immunomodulating Agents (22)
Schedule	Section 100 (CT) (22)
Prescriber	Medical Practitioners (22)

ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial atezolizumab 1.2 g/20 mL injection, 20 mL vial atezolizumab 840 mg/14 mL injection, 14 mL vial

DARATUMUMAB daratumumab 1.8 g/15 mL injection, 15 mL vial daratumumab 100 mg/5 mL injection, 5 mL vial daratumumab 400 mg/20 mL injection, 20 mL vial

EPCORITAMAB epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial

MYCOBACTERIUM BOVIS BCG DANISH STRAIN Mycobacterium bovis BCG Danish strain 30 mg injection, 4 vials

MYCOBACTERIUM BOVIS BCG TICE STRAIN Mycobacterium bovis BCG Tice strain 500 million CFU injection, 3 vials

TRASTUZUMAB trastuzumab 600 mg/5 mL injection, 5 mL vial trastuzumab 150 mg injection, 1 vial trastuzumab 60 mg injection, 1 vial trastuzumab 420 mg injection, 1 vial trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack